Pharmaceutics
Selective Nanoparticulate Systems for Drug Delivery in Inflammatory Bowel Disease.
Alberta Ribeiro, Rute Nunes
Published: 202510.3390/pharmaceutics18010055
Abstract
Inflammatory bowel disease is a result of inappropriate continuous non-specific inflammation in the intestinal tract, which in turn is aggravated by defects in the activation of the mucosal immune system and in the barrier function of the intestinal…
Preview only. Read the full abstract at the source